| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |